Greater Bay Biotechnology Limited

Greater Bay Biotechnology (GBBT) is a business supported by the City University of Hong Kong (CityUHK) HK Tech 300 program, Hong Kong Shenzhen Innovation and Technology Park (HSITP), and the HKSAR Government Innovation and Technology Fund. GBBT focuses on the research, development, and commercialisation of transdermal drug and cell delivery technology for the treatment of both local and systemic diseases.